| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Ann Thorac Surg 1997;64:623-627
© 1997 The Society of Thoracic Surgeons
Section of Thoracic Surgery, University of Michigan Medical Center, Ann Arbor, Michigan, National Institute of Drug Abuse, Baltimore, Maryland and Department of Pathology, University of Kentucky, Lexington, Kentucky
Background. Hypothermic cardioplegia provides adequate myocellular protection, yet stunning and dysfunction remain significant problems. Interestingly, the subcellular changes of hibernation parallel the altered biology of induced cardiac ischemia, but are well tolerated by hibernating mammalian myocardium. Hibernation induction trigger (HIT) from winter-hibernating animal serum induces hibernation in active animals. Hibernation induction trigger is opiate in nature and is similar to the delta 2 opioids.
Methods. To determine whether HIT could improve myocardial recovery following global ischemia, we gave 37 isolated rabbit hearts either standard cardioplegia or cardioplegia containing summer-active woodchuck, hibernating woodchuck, or black bear HIT serum or a delta 2 opioid, D-Ala2-Leu5-enkephalin, before 2 hours of global ischemia.
Results. Hibernation induction trigger appeared not to have an active mechanism during ischemia, as all hearts had equal recovery. In contrast, when examining for a preischemia mechanism, 23 additional rabbits received 3 days pretreatment with summer-active woodchuck or HIT hibernating woodchuck or black bear serum, or were preperfused with D-Ala2-Leu5-enkephalin or D-pen2,5-enkephalin, a delta 1 opioid, again before 2 hours of global ischemia. Postischemic ventricular function, coronary flows, myocardial oxygen consumption, and ultrastructural preservation were all significantly improved with HIT and D-Ala2-Leu5-enkephalin pretreatment.
Conclusion. "Natural" HIT protection is superior to standard cardioplegia alone and may have clinical application.
This article has been cited by other articles:
|
|
 |
|
  A. A. El-Menyar The Resuscitation Outcome: Revisit the Story of the Stony Heart Chest, October 1, 2005; 128(4): 2835 - 2846. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Smith Sonneborn, H. Gottsch, E. Cubin, P. Oeltgen, and P. Thomas Alternative Strategy for Stress Tolerance: Opioids J. Gerontol. A Biol. Sci. Med. Sci., May 1, 2004; 59(5): B433 - B440. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Nicolini, C. Beghi, C. Muscari, A. Agostinelli, A. M. Budillon, I. Spaggiari, and T. Gherli Myocardial protection in adult cardiac surgery: current options and future challenges Eur. J. Cardiothorac. Surg., December 1, 2003; 24(6): 986 - 993. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Kato and P. Foex Myocardial protection by anesthetic agents against ischemia-reperfusion injury: an update for anesthesiologists: [La protection myocardique contre les lesions d'ischemie-reperfusion par des anesthesiques : une mise a jour pour les anesthesiologistes] Can J Anesth, October 1, 2002; 49(8): 777 - 791. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. C. Sigg, J. A. Coles Jr., P. R. Oeltgen, and P. A. Iaizzo Role of delta -opioid receptor agonists on infarct size reduction in swine Am J Physiol Heart Circ Physiol, June 1, 2002; 282(6): H1953 - H1960. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. B. Becker, M. L. Weisfeldt, M. H. Weil, T. Budinger, J. Carrico, K. Kern, G. Nichol, I. Shechter, R. Traystman, C. Webb, et al. The PULSE Initiative: Scientific Priorities and Strategic Planning for Resuscitation Research and Life Saving Therapies Circulation, May 28, 2002; 105(21): 2562 - 2570. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Karck, S. Tanaka, S. F. Bolling, A. Simon, T.-P. Su, P. R. Oeltgen, and A. Haverich Myocardial protection by ischemic preconditioning and {delta}-opioid receptor activation in the isolated working rat heart J. Thorac. Cardiovasc. Surg., November 1, 2001; 122(5): 986 - 992. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. C. Sigg, J. A. Coles Jr, W. J. Gallagher, P. R. Oeltgen, and P. A. Iaizzo Opioid preconditioning: myocardial function and energy metabolism Ann. Thorac. Surg., November 1, 2001; 72(5): 1576 - 1582. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. F. Bolling, V. Badhwar, C. F. Schwartz, P. R. Oeltgen, K. Kilgore, and T.-P. Su Opioids confer myocardial tolerance to ischemia: Interaction of delta opioid agonists and antagonists J. Thorac. Cardiovasc. Surg., September 1, 2001; 122(3): 476 - 481. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Schulz, P. Gres, and G. Heusch Role of endogenous opioids in ischemic preconditioning but not in short-term hibernation in pigs Am J Physiol Heart Circ Physiol, May 1, 2001; 280(5): H2175 - H2181. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. E. Johnston Preconditioning the Brain and Heart: Implications for Cardiac Surgery Seminars in Cardiothoracic and Vascular Anesthesia, July 1, 2000; 4(2): 70 - 79. [Abstract] [PDF]
|
|
|
|
|
|
P. E. Benedict, M. B. Benedict, T.-P. Su, and S. F. Bolling Opiate Drugs and {delta}-Receptor-Mediated Myocardial Protection Circulation, November 9, 1999; 100(90002): II-357 - 360. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. S. Jahania, J. A. Sanchez, P. Narayan, R. D. Lasley, and R. M. Mentzer Jr Heart preservation for transplantation: principles and strategies Ann. Thorac. Surg., November 1, 1999; 68(5): 1983 - 1987. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Kevelaitis, J. Peynet, C. Mouas, J.-M. Launay, and P. Menasche Opening of Potassium Channels : The Common Cardioprotective Link Between Preconditioning and Natural Hibernation? Circulation, June 15, 1999; 99(23): 3079 - 3085. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. HEUSCH Hibernating Myocardium Physiol Rev, October 1, 1998; 78(4): 1055 - 1085. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
